MX2009004186A - Derivados de 2-fenil-6-aminocarbonil-pirimidina. - Google Patents
Derivados de 2-fenil-6-aminocarbonil-pirimidina.Info
- Publication number
- MX2009004186A MX2009004186A MX2009004186A MX2009004186A MX2009004186A MX 2009004186 A MX2009004186 A MX 2009004186A MX 2009004186 A MX2009004186 A MX 2009004186A MX 2009004186 A MX2009004186 A MX 2009004186A MX 2009004186 A MX2009004186 A MX 2009004186A
- Authority
- MX
- Mexico
- Prior art keywords
- aminocarbonyl
- phenyl
- pyrimidine derivatives
- treatment
- vascular
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invención se relaciona con derivados de 2-fenil-6-aminocarbonil-pirimidina y su uso como antagonistas del receptor P2Y12 en el tratamiento y/o la prevención de enfermedades vasculares periféricas, viscerales, hepáticas y renales, de enfermedades cardiovasculares y cerebrovasculares, o de estados asociados con la agregación de plaquetas, incluyendo trombosis, en los humanos y en otros mamíferos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IB2006053929 | 2006-10-25 | ||
PCT/IB2007/054325 WO2008050301A2 (en) | 2006-10-25 | 2007-10-24 | 2- phenyl- 6-aminocarbonyl- pyrimidine derivatives and their use as p2y12 receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009004186A true MX2009004186A (es) | 2009-05-11 |
Family
ID=39324985
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009004186A MX2009004186A (es) | 2006-10-25 | 2007-10-24 | Derivados de 2-fenil-6-aminocarbonil-pirimidina. |
Country Status (22)
Country | Link |
---|---|
US (1) | US8044055B2 (es) |
EP (1) | EP2079711B1 (es) |
JP (1) | JP5144670B2 (es) |
KR (1) | KR101434697B1 (es) |
CN (1) | CN101528715B (es) |
AR (1) | AR063518A1 (es) |
AT (1) | ATE454377T1 (es) |
AU (1) | AU2007310435A1 (es) |
BR (1) | BRPI0717369A2 (es) |
CA (1) | CA2664347C (es) |
CL (1) | CL2007003038A1 (es) |
DE (1) | DE602007004245D1 (es) |
ES (1) | ES2339408T3 (es) |
IL (1) | IL198334A0 (es) |
MA (1) | MA30903B1 (es) |
MX (1) | MX2009004186A (es) |
NO (1) | NO20091985L (es) |
PL (1) | PL2079711T3 (es) |
RU (1) | RU2009119421A (es) |
TW (1) | TW200829247A (es) |
WO (1) | WO2008050301A2 (es) |
ZA (1) | ZA200903574B (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200640877A (en) | 2005-04-28 | 2006-12-01 | Actelion Pharmaceuticals Ltd | Pyrimidine derivatives |
CL2007002920A1 (es) | 2006-10-13 | 2008-06-06 | Actelion Pharmaceuticals Ltd | Compuestos derivados de 2-aminocarbonilpiridina; composicion farmaceutica; y uso para el tratamiento de trastornos vasculares oclusivos. |
US8518912B2 (en) | 2007-11-29 | 2013-08-27 | Actelion Pharmaceuticals Ltd. | Phosphonic acid derivates and their use as P2Y12 receptor antagonists |
AR071652A1 (es) | 2008-04-11 | 2010-07-07 | Actelion Pharmaceuticals Ltd | Derivados 2- fenil-piridina substituidos |
AR071653A1 (es) | 2008-04-11 | 2010-07-07 | Actelion Pharmaceuticals Ltd | Derivados 2-fenil-4-ciclopropil-pirimidina |
US8288385B2 (en) | 2009-04-08 | 2012-10-16 | Actelion Pharmaceuticals Ltd. | 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines |
AU2010240527A1 (en) | 2009-04-22 | 2011-12-01 | Actelion Pharmaceuticals Ltd | Thiazole derivatives and their use as P2Y12 receptor antagonists |
WO2013033178A1 (en) | 2011-08-30 | 2013-03-07 | University Of Utah Research Foundation | Methods and compositions for treating nephrogenic diabetes insipidus |
CN102992968B (zh) * | 2012-08-15 | 2014-07-16 | 河北工业大学 | 2,3-二甲氧基-1-丙醇及其制备方法 |
UA124073C2 (uk) | 2016-09-22 | 2021-07-14 | Ідорсія Фармасьютікалз Лтд | Кристалічні форми гідрохлориду складного бутилового ефіру 4-((r)-2-{[6-((s)-3-метоксипіролідин-1-іл)-2-фенілпіримідин-4-карбоніл]-аміно}-3-фосфонопропіоніл)-піперазин-1-карбонової кислоти |
CA3050831A1 (en) | 2017-03-15 | 2018-09-20 | Idorsia Pharmaceuticals Ltd | Subcutaneous administration of a p2y12 receptor antagonist |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5373586A (en) * | 1976-12-09 | 1978-06-30 | Mitsubishi Chem Ind Ltd | New penicillin derivatives |
JPS61227572A (ja) * | 1985-04-02 | 1986-10-09 | Ishihara Sangyo Kaisha Ltd | N−ベンゾイル−n′−ピリミジニルオキシフエニルウレア系化合物及びそれらを含有する抗癌剤 |
JP2003502314A (ja) | 1999-06-14 | 2003-01-21 | イーライ・リリー・アンド・カンパニー | 化合物 |
US6861424B2 (en) * | 2001-06-06 | 2005-03-01 | Schering Aktiengesellschaft | Platelet adenosine diphosphate receptor antagonists |
CN1181062C (zh) * | 2001-12-28 | 2004-12-22 | 陈依军 | 2-苯氧基嘧啶衍生物及其治疗用途 |
JP4662777B2 (ja) * | 2002-12-11 | 2011-03-30 | バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト | 血小板アデノシン二リン酸受容体アンタゴニストとしての2−アミノカルボニルキノリン化合物 |
TW200640877A (en) * | 2005-04-28 | 2006-12-01 | Actelion Pharmaceuticals Ltd | Pyrimidine derivatives |
CL2007002920A1 (es) | 2006-10-13 | 2008-06-06 | Actelion Pharmaceuticals Ltd | Compuestos derivados de 2-aminocarbonilpiridina; composicion farmaceutica; y uso para el tratamiento de trastornos vasculares oclusivos. |
US8518912B2 (en) | 2007-11-29 | 2013-08-27 | Actelion Pharmaceuticals Ltd. | Phosphonic acid derivates and their use as P2Y12 receptor antagonists |
AR071653A1 (es) | 2008-04-11 | 2010-07-07 | Actelion Pharmaceuticals Ltd | Derivados 2-fenil-4-ciclopropil-pirimidina |
AR071652A1 (es) | 2008-04-11 | 2010-07-07 | Actelion Pharmaceuticals Ltd | Derivados 2- fenil-piridina substituidos |
US8288385B2 (en) | 2009-04-08 | 2012-10-16 | Actelion Pharmaceuticals Ltd. | 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines |
AU2010240527A1 (en) | 2009-04-22 | 2011-12-01 | Actelion Pharmaceuticals Ltd | Thiazole derivatives and their use as P2Y12 receptor antagonists |
-
2007
- 2007-10-23 AR ARP070104678A patent/AR063518A1/es unknown
- 2007-10-23 CL CL200703038A patent/CL2007003038A1/es unknown
- 2007-10-24 PL PL07826850T patent/PL2079711T3/pl unknown
- 2007-10-24 RU RU2009119421/04A patent/RU2009119421A/ru not_active Application Discontinuation
- 2007-10-24 AU AU2007310435A patent/AU2007310435A1/en not_active Abandoned
- 2007-10-24 ES ES07826850T patent/ES2339408T3/es active Active
- 2007-10-24 EP EP07826850A patent/EP2079711B1/en active Active
- 2007-10-24 TW TW096139907A patent/TW200829247A/zh unknown
- 2007-10-24 US US12/447,039 patent/US8044055B2/en active Active
- 2007-10-24 JP JP2009534029A patent/JP5144670B2/ja active Active
- 2007-10-24 AT AT07826850T patent/ATE454377T1/de active
- 2007-10-24 DE DE602007004245T patent/DE602007004245D1/de active Active
- 2007-10-24 CN CN2007800399452A patent/CN101528715B/zh active Active
- 2007-10-24 KR KR1020097009600A patent/KR101434697B1/ko active IP Right Grant
- 2007-10-24 CA CA2664347A patent/CA2664347C/en active Active
- 2007-10-24 BR BRPI0717369-5A2A patent/BRPI0717369A2/pt not_active IP Right Cessation
- 2007-10-24 MX MX2009004186A patent/MX2009004186A/es active IP Right Grant
- 2007-10-24 WO PCT/IB2007/054325 patent/WO2008050301A2/en active Application Filing
-
2009
- 2009-04-23 IL IL198334A patent/IL198334A0/en unknown
- 2009-05-15 MA MA31890A patent/MA30903B1/fr unknown
- 2009-05-22 NO NO20091985A patent/NO20091985L/no not_active Application Discontinuation
- 2009-05-22 ZA ZA200903574A patent/ZA200903574B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
WO2008050301A2 (en) | 2008-05-02 |
CL2007003038A1 (es) | 2008-06-06 |
TW200829247A (en) | 2008-07-16 |
MA30903B1 (fr) | 2009-11-02 |
PL2079711T3 (pl) | 2010-06-30 |
ZA200903574B (en) | 2010-08-25 |
CA2664347C (en) | 2014-10-21 |
DE602007004245D1 (de) | 2010-02-25 |
AU2007310435A1 (en) | 2008-05-02 |
JP2010507646A (ja) | 2010-03-11 |
KR101434697B1 (ko) | 2014-08-27 |
AR063518A1 (es) | 2009-01-28 |
BRPI0717369A2 (pt) | 2014-10-07 |
RU2009119421A (ru) | 2011-04-27 |
US20090291962A1 (en) | 2009-11-26 |
CA2664347A1 (en) | 2008-05-02 |
WO2008050301A3 (en) | 2008-10-09 |
US8044055B2 (en) | 2011-10-25 |
ES2339408T3 (es) | 2010-05-19 |
EP2079711B1 (en) | 2010-01-06 |
IL198334A0 (en) | 2010-02-17 |
CN101528715A (zh) | 2009-09-09 |
JP5144670B2 (ja) | 2013-02-13 |
CN101528715B (zh) | 2011-08-24 |
KR20090068278A (ko) | 2009-06-25 |
ATE454377T1 (de) | 2010-01-15 |
EP2079711A2 (en) | 2009-07-22 |
NO20091985L (no) | 2009-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200640877A (en) | Pyrimidine derivatives | |
MX2009004186A (es) | Derivados de 2-fenil-6-aminocarbonil-pirimidina. | |
MX2009003724A (es) | Derivados de 2-aminocarbonil-piridina. | |
MY153749A (en) | Phosphonic acid derivates and their use as p2y12 receptor antagonists | |
WO2010116328A3 (en) | 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines as adp receptor antagonists | |
MX2011009539A (es) | 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso. | |
UA115887C2 (uk) | АМІНОЗАМІЩЕНІ ІМІДАЗО[1,2-а]ПІРИДИНКАРБОКСАМІДИ І ЇХ ЗАСТОСУВАННЯ | |
UA102065C2 (en) | Substituted 4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof | |
TW200716140A (en) | Treatment of inflammatory conditions | |
NZ596388A (en) | Thiazole derivatives and their use as p2y12 receptor antagonists | |
PH12015501806B1 (en) | Novel benzopyran kinase modulators | |
WO2006091459A3 (en) | Compositions and methods for treating vascular permeability | |
MY161495A (en) | Virus like particle compositions and methods of use | |
MY173616A (en) | Compositions and methods for lowering triglycerides | |
EA201001639A1 (ru) | Композиции и способы их получения и применения | |
TW200736275A (en) | Methods and compositions for treating allergic diseases | |
MY147247A (en) | Organic compounds and their uses | |
MA32277B1 (fr) | Derives de 2-phenyl-4- cyclopropyl-pyrimidine | |
JO2721B1 (en) | Derivatives of artemisia plant and its preparations and therapeutic applications | |
IN2012DN02471A (es) | ||
BRPI0808043A2 (pt) | Compostos tricíclicos úteis no tratamento de distúrbios de ferro. | |
MX342947B (es) | Tratamiento de diabetes tipo 2. | |
MY150931A (en) | Substituted oxazolidinones and their use | |
MY164998A (en) | Isoquinolinone derivatives as nk3 antagonists | |
CO6290689A2 (es) | Derivados de 1,2,3,4-tetrahidropirrolo[1,2]pirazina-6-carboxamidas y de 2,3,4,5-tetrahidropirrol[1,2][1,4]-diazepina -7-carboxamidas su preparacion y su aplicacion en terapeutica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |